Vycor Medical, Inc.

Vycor Medical, Inc. operates two distinct business units specializing in neurosurgical and neurotherapeutic solutions. The primary division designs and manufactures neurosurgical medical devices, with the ViewSite Brain Access System (VBAS) as the flagship product—a minimally invasive neurosurgical device that improves access to brain lesions while reducing tissue damage. Clinical evidence from over 50 studies demonstrates VBAS results in reduced brain tissue trauma, minimized invasiveness, improved surgical visibility, and shortened operating and recovery times. The company's secondary business unit, NovaVision, develops non-invasive, computer-based vision rehabilitation therapies for patients with vision loss resulting from neurological trauma such as stroke. NovaVision Visual Restoration Therapy (VRT) is the only FDA-cleared therapy for vision rehabilitation following neurological brain damage; it is complemented by the NeuroEyeCoach program, which trains patients to make improved eye movements to enhance visual field detection. Vycor Medical serves neurosurgeons, neurologists, rehabilitation specialists, and vision care providers across hospital and outpatient settings. The company holds FDA regulatory clearance for its therapeutic products and demonstrates commitment to clinical validation and evidence-based outcomes.